Aims Cardiac hypertrophy by activation of the b-adrenergic receptor (bAR) is mediated more efficiently by the b 1 -AR than by the b 2 -AR. We investigated the signalling mechanism by which the b 1 -AR mediates cardiac hypertrophy. 
Introduction
Several patho-physiological conditions in the heart elevate sympathetic nervous activity, which causes cardiac hypertrophy through stimulating the b-adrenergic receptor (b-AR) signalling. 1, 2 Sustained stimulation of b-ARs leads to reduced cardiac function and development of congestive heart failure. 3 Conversely, treatment of heart failure patients with b-AR antagonists prevents progression of cardiac dysfunction and reduces mortality. 2 We have shown that hypertrophy of cultured cardiac myocytes produced by stimulation of endogenous b-ARs is more efficiently mediated by b 1 -ARs compared with b 2 -ARs despite the fact that both b 1 -and b 2 -ARs are expressed in this cell type. 4 Efficient coupling of the b 1 -AR with cardiac hypertrophy over the b 2 -AR has also been suggested in transgenic mice studies, which utilize overexpression of the b-AR subtypes in the heart. [5] [6] [7] Although long-term (.1 year) overexpression of b 2 -ARs in the mouse heart eventually causes cardiomyopathy, the mechanisms by which b 1 -and b 2 -ARs mediate cardiomyopathy seem distinct: inhibition of p38-MAPK reduces cardiac dysfunction in b 2 -AR overexpressed mice but not in b 1 -AR overexpressed ones. 8 At present, however, the mechanisms by which b 1 -and b 2 -ARs differentially mediate cardiac hypertrophy are not clearly understood. This issue is important, since modulating the function of b-AR subtypes has been considered as a possible treatment for congestive heart failure. 9 The myocardial b 1 -and b 2 -ARs couple to substantially different signalling mechanisms. 10 Ligand binding to the b 1 -AR causes activation of the a subunit of the heterotrimeric G protein, Gas, while the b 2 -AR couples to both Gas and Gai.
10 b 1 -and b 2 -ARs differentially affect contractile properties and intracellular Ca 2þ transients in cardiac myocytes. 10 However, intracellular mediators of cardiac hypertrophy stimulated by the b 1 -AR have not been fully understood.
The b-ARs are phosphorylated and internalized upon ligand binding. Multiple molecules, including Gbg, b-AR kinase (b-ARK), b-arrestin-1, Src, dynamin, and clathrin, are involved in the initial process of b-AR internalization via clathrin-coated pits. 11 Although receptor internalization has been traditionally portrayed as a mechanism to terminate receptor signalling, it could mediate activation of signalling molecules, such as MAP kinases, 11 which in turn play a key role in mediating cell growth responses by G protein-coupled receptors (GPCRs). Whether or not such endocytosis-dependent signalling mechanisms mediate cardiac hypertrophy remains to be elucidated.
In this study, we examined the signalling mechanism by which the b 1 -AR stimulates cardiac hypertrophy. Since our initial observation indicated that the b 1 -AR is internalized after stimulation with agonists in a more prolonged fashion than the b 2 -AR in cardiac myocytes, we examined the role of receptor endocytosis in mediating b-AR-induced cardiac hypertrophy.
Experimental procedures 2.1 Materials
PP1 was obtained from Biomol (Plymouth Meeting, PA, USA).
Primary cultures of neonatal rat ventricular myocytes
Primary cultures of cardiac ventricular myocytes from 1-day-old Crl:(WI)BR-Wistar rats (Charles River Laboratories, Wilmington, MA, USA) were prepared as described. 4 The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health. Myocytes were cultured in serum-free conditions for 48 h before experiments.
Receptor-binding assays
Receptor binding for intact cells was performed as described by Morisco et al. 4 Myocytes were rinsed with a binding buffer containing Opti-MEM (Invitrogen, Carlsbad, CA, USA) supplemented with 0.1% bovine serum albumin, 0.1 mg/mL bacitracin, and incubated with (2)-[
125 I]iodocyanopindolol ([  125 I ]CYP, 0.1 pM-3 nM, specific activity 2200 Ci/mmol, Perkin Elmer, Waltham, MA, USA) in the assay (0.3 mL) buffer for 1 h at 378C. Myocytes were washed with the binding buffer. To determine the cell surface ligand binding, cells were exposed to 50 mM glycine-150 mM NaCl, pH 3, for 10 min at 48C. The cell surface-bound radioactivity was collected by aspiration of the acid wash solution and three rinses with ice-cold Opti-MEM. The cell-associated radioactivity was measured by harvesting cells, and both fractions were quantitated by gamma counting. To determine the total cellular ligand binding, myocytes were incubated with 1 mL of 5% trichloroacetic acid (TCA) for 1 h at 48C. Radioactivity released in TCA was counted. Specific binding of [ B max and dissociation constant (K d ) were determined from saturation binding curves using non-linear-fitting curves (GraphPad, San Diego, CA, USA). The analysis of b-AR subtypes was performed as described previously. 4 
Transient transfection and reporter gene assays
Transfection was carried out using atrial natriuretic factor (ANF)-Luc (2638) (1 mg) 12 or a plasmid containing the yeast GAL4-binding sites linked to firefly luciferase (pFR-Luc) together with a plasmid containing the activation domain of CREB fused with the GAL4 DNA-binding domain (GAL4-CREB). To correct for differences in the transfection efficiency, an SV40 driven b-galactosidase plasmid (SV40-bgal) was co-transfected.
Immunoblotting
Akt activity was determined using anti-phospho-Akt (Serine 473) antibody (Cell Signaling Technology, Danvers, MA, USA). For the analysis of Src, myocytes were lysed with lysis buffer containing 150 mM NaCl, 15 mM HEPES (pH 7.0), 0.1% SDS, 1% NP-40, 1% Na-deoxycholate, 2 mM EDTA, 50 mM NaF, 1 mM Na vanadate, 10 mg/mL aprotinin, 10 mg/mL trypsin inhibitor, and 10 mg/mL leupeptin. Src activity was determined using anti-phospho-Src (Tyrosine 416) antibody (Cell Signaling Technology). 
Adenovirus transduction

Statistics
Data are given as mean + SEM. Statistical analyses were performed using the analysis of variance. The post-test comparison was performed by the method of Tukey. Significance was accepted at the P , 0.05 level.
Results
The b 1 -AR is selectively internalized following isoproterenol stimulation
We initially hypothesized that differences in ligand binding-induced downregulation between b 1 -and b 2 -ARs may explain differences in the hypertrophic effects of b 1 -and b 2 -ARs. 4 We examined downregulation of the b-ARs in response to isoproterenol (ISO), a non-selective agonist for the b-AR, using hydrophobic radioligand 4 if endocytosis only terminates the cell signalling through b-ARs. However, since the endocytosis machinery could actively mediate some signalling mechanisms, 11 we hypothesized that the endocytosis machinery mediates ISO-induced cardiac hypertrophy.
Concanavalin A inhibits isoproterenol-induced increases in protein/DNA content and atrial natriuretic factor transcription
Since Con A prevented endocytosis of the b 1 -AR, we examined the effect of Con A on ISO-induced increases in the protein/DNA content (protein/DNA) and ANF transcription, major features of ISO-induced cardiac hypertrophy. 4 Forty-eight-hour stimulation of myocytes with ISO significantly increased protein/DNA, consistent with our previous observation. 4 Con A did not affect basal protein/DNA, but it significantly inhibited ISO-induced increases in protein/DNA ( Figure 1A ). In contrast, Con A did not significantly affect FBS-induced increases in protein/DNA ( Figure 1A) , suggesting that the effect of Con A on ISO-induced increases in protein/DNA is specific. Con A significantly inhibited ISO-induced increases in ANF transcription ( Figure 1B) . On the other hand, Con A affected neither ISO-induced increases in cAMP production ( Figure 1C ) nor ISO-induced increases in the GAL4-CREB activity ( Figure 1D ), suggesting that Con A does not globally affect b-AR-mediated signalling mechanisms. Taken together, Con A-sensitive mechanisms, such as internalization of the b 1 -AR, play an essential role in mediating ISO-induced cardiac hypertrophy.
Gbg mediates isoproterenol-induced increases in atrial natriuretic factor transcription
Upon ligand binding to the b-ARs, Gbg subunits are dissociated from Gsa. Gbg physically interacts with b-ARK-1, thereby allowing b-ARK-1 to phosphorylate the b-ARs. Thus, Gbg is critically involved in the endocytosis of the b-ARs.
11 Co-expression of Gb2 and Gg2 dose-dependently stimulated ANF-Luc reporter gene activity in myocytes ( Figure 2A) . Thus, increased expression of the Gbg subunit is sufficient to stimulate ANF transcription.
b-ARK-CT inhibits the cell signalling mediated by Gbg. 
Dominant negative b-arrestin-1 and dominant negative dynamin block isoproterenol-induced cardiac hypertrophy
We further examined whether the endocytosis machinery plays a key role in mediating ISO-induced cardiac hypertrophy. DN b-arrestin-1 [b-arrestin-1 (319-418)] binds to clathrin cages but fails to interact with b-ARs, thereby preventing endocytosis of the b-ARs. 15 Transfection of DN b-arrestin-1 inhibited ISO-induced increases in ANF transcription ( Figure 3A) . DN dynamin inhibits clathrin-coated vesicle-mediated endocytosis. 16 Transduction of adenovirus vector harbouring DN dynamin significantly inhibited ISOinduced increases in protein/DNA ( Figure 3B ) and ANF transcription ( Figure 3C ). In contrast, control adenovirus did not affect ISO-induced increases in protein/DNA. These results are consistent with the notion that the endocytosis machinery plays an important role in mediating b-adrenergic cardiac hypertrophy.
Isoproterenol-induced activation of Akt is mediated by b 1 -ARs and receptor endocytosis-dependent mechanisms
We next examined which endocytosis-dependent signalling mechanism mediates b-adrenergic cardiac hypertrophy. We have shown previously that members of the MAP kinase family do not mediate ISO-induced increases in ANF transcription, whereas Akt plays an important role in mediating b-AR-induced cardiac hypertrophy. 12 ISO as low as 0.1 mM induced Akt phosphorylation in cardiac myocytes (Supplementary material online, Figure S1 ). We examined whether internalization of the b-AR is required for b-AR-induced activation of Akt. ISO-induced increases in In order to test whether Akt plays an essential role in ISOinduced cardiac hypertrophy, we examined the effect of adenovirus-mediated transduction of DN Akt on ISO-induced increases in protein/DNA in cardiac myocytes. DN Akt significantly suppressed ISO-induced increases in the protein/DNA ( Figure 4D) . Transduction of control adenovirus did not affect ISO-induced increases in protein/DNA. These results suggest that activation of the endocytosis machinery by the b-AR causes activation of Akt, which in turn mediates b-adrenergic cardiac hypertrophy.
Src plays an essential role in isoproterenol-induced Akt activation and cardiac hypertrophy
Recruitment of c-Src to the receptor is involved in the mechanism leading to receptor internalization and activation of downstream signalling molecules, such as MAP kinases, in response to b-AR stimulation. 17 We therefore examined whether Src is activated by ISO in cardiac myocytes. ISO stimulation caused increases in the tyrosine kinase activity as well as Tyr 416 phosphorylation of Src ( Figure 5A and Supplementary material online, Figure S1 ). Interestingly, ISO-induced activation of Akt was blocked in the presence of the Src-specific inhibitor PP1 ( Figure 5B ), suggesting that ISO-induced activation of Akt is mediated by Src.
To determine whether activation of Src is required for b-AR-induced cardiac hypertrophy, we examined the effect of inhibition of Src on ISO-induced cardiac hypertrophy. ISOinduced increases in the protein/DNA were significantly inhibited by PP1 ( Figure 5C ). PP1 also significantly inhibited ISO-induced increases in actin reorganization, as determined by FITC-phalloidin staining ( Figure 5D ). DN Src dose-dependently inhibited ISO-induced increases in ANF transcription ( Figure 5E ). These results suggest that Src plays an essential role in mediating b-AR-induced cardiac hypertrophy. Although constitutively active Src stimulated ANF transcription, it did not do so as strongly as ISO ( Figure 5F ). Additional signalling mechanisms may be required for full activation of ANF transcription by ISO.
Discussion
In the present investigation, we studied the signalling mechanism by which the b 1 -AR mediates cardiac hypertrophy in response to b-AR stimulation ( Figure 6 ). Our results suggest that the b 1 -AR undergoes prolonged endocytosis (.4 h) after ISO stimulation and that activation of the endocytosis machinery, instead of turning off the signal through the b-AR, positively mediates b-AR-induced cardiac hypertrophy. Furthermore, the endocytosis machinery is required for Akt activation, which in turn mediates cardiac hypertrophy in response to b-AR stimulation. Internalization-evoked signalling of GPCRs is required for cytoprotection in ischaemic pre-conditioning 18 and impairment of cardiac function following mechanical stress. 19 However, the requirement of the endocytosis machinery in cardiac hypertrophy has not been previously demonstrated.
After ISO stimulation, the number of b 1 -ARs on the cell surface was decreased while that of b 2 -ARs was preserved. b-AR, 17, 20, 21 inhibited ISO-induced increases in ANF transcription and myocyte hypertrophy. These results are consistent with the notion that endocytosis of the b 1 -AR itself or activation of the endocytosis machinery is required for ISO-induced cardiac hypertrophy.
Internalization of the b-AR and/or accompanying clathrincoated vesicle endocytosis plays a critical role in activation of downstream MAP kinases. 11 Our results suggest that the endocytosis machinery is required for ISO-induced activation of Akt. The requirement of endocytosis for agonist-induced Akt activation has not been demonstrated in cardiac myocytes. We believe that Akt is the key signalling molecule which connects the endocytosis machinery and b-adrenergic hypertophy, because activation of Akt is necessary, whereas MAP kinases are not critically required, for b-adrenergic cardiac hypertrophy. 12 Although activation of Akt could cause pathological hypertrophy, 22 it may not mediate every aspect of hypertrophy by stimulation of the b 1 -AR. Thus, a possibility remains that other signalling molecules regulated by the endocytosis machinery may also participate in the pathogenesis of b 1 -AR-mediated cardiac hypertrophy. Whether the endocytosis machinery and subsequent activation of Akt are protective or detrimental for the heart in the long term remains to be elucidated.
In response to the stimulation of the b 2 -AR receptor, Src is recruited to the membrane through interaction with b-arrestin-1 and phosphorylates proteins involved in clathrin-mediated endocytosis, such as dynamin and clathrin heavy chain. 17, 23 We have shown that both activation of Src and receptor endocytosis are essential for b-adrenergic activation of Akt. That Src might directly regulate Akt seems unlikely because we could not obtain evidence that Src and Akt physically interact with one another (our unpublished observation). Alternatively, Src may regulate phosphatidylinositol 3 0 kinase or Ca 2þ /calmodulindependent kinase, since both of these molecules are required for ISO-induced Akt activation in cardiac myocytes. 12 Phosphatidylinositol 3 0 kinase is recruited to the membrane in response to the stimulation of the b-AR in the heart. 24 At present, we do not know yet whether Ca 2þ -dependent mechanisms are involved upstream or downstream of the endocytosis machinery.
Norepinephrine (NE), a physiological ligand for the b-AR, mediates hypertrophy also through a 1 -AR. Phenylephrine (PE), an agonist for the a 1 -AR, modestly activated Akt (Supplementary material online, Figure S2 ), and PE-induced activation of Akt was inhibited by Con A (Supplementary material online, Figure S3 ). Although the effect of PE may be partly mediated by the b-AR, these results suggest a possibility that the endocytosis machinery may be involved Figure S2 ). Stimulation of a 1 -or b-ARs induces hypertrophy in cultured adult cardiac myocytes. 25 Whether or not the endocytosis-dependent signalling mechanism is critical for NE-induced hypertrophy in adult myocytes remains to be tested. b 1 -and b 2 -ARs internalize with distinct time courses in fibroblasts. 26 The time course and the extent of internalization of the b-AR subtypes substantially differ among various cell types. Differences in the expression level of intermediates required for endocytosis and distinct affinities of the b-AR subtypes for those intermediates may contribute to the distinct properties of receptor endocytosis among b-AR subtypes in various cell types. 27 Although the involvement of b-ARKs and b-arrestin-1, a well-established mechanism for endocytosis of the b 2 -AR, has been suggested as a mechanism for endocytosis of the b 1 -AR, 21, 28 other mechanisms may also mediate internalization of the b 1 -AR. For example, endophilins specifically interact with the intracellular third loop of the b 1 -AR. 29 Whether or not such a unique intermediate is responsible for the selective hypertrophic effects of the b 1 -AR is unknown. Alternatively, localization of b-ARs on the cell surface, and their association with caveolae, another important mechanism mediating endocytosis, may differ depending upon cell type.
30 b 2 -ARs are predominantly localized to the caveolar space, whereas b 1 -ARs distribute between caveolae and other cell fractions in neonatal rat cardiac myocytes. 31 Another interesting finding in this study was that overexpression of Gbg stimulated ANF transcription and that expression of b-ARK-CT, a molecule which inhibits Gbg-mediated signalling, 14 significantly inhibited b-adrenergic cardiac hypertrophy. These results suggest that Gbg plays an important role in b-adrenergic cardiac hypertrophy. Since b-ARK-1 is targeted to the b-ARs via its affinity for Gbg, 28 and because Gbg binding is necessary for b-ARK-1 activation, 32 Gbg may play a critical role in mediating b-AR-induced cardiac hypertrophy through its effects on b-AR internalization. Alternatively, signalling molecules directly activated by a Gbg-dependent mechanism, including phosphatidylinositol 3 0 -kinases, 33 may also be involved in b-adrenergic cardiac hypertrophy. Overexpression of b-ARK-CT in transgenic mice failed to prevent pressure overload-induced cardiac hypertrophy, 34 but did decrease hypertrophy caused by the myosin heavy chain missense mutation. 28 Whether or not cardiac hypertrophy in vivo caused by agonists for GPCR is mediated by Gbg-dependent mechanisms has not been elucidated.
In summary, our results indicate that b 1 -ARs, compared with b 2 -ARs, undergo prolonged endocytosis upon ligand binding in cardiac myocytes and that activation of the endocytosis machinery is required for activation of Akt, which in turn mediates cardiac hypertrophy ( Figure 6 ). Many GPCRs mediate cardiac hypertrophy, which generally requires longterm stimulation with agonists, despite the fact that they undergo internalization. If endocytosis of other GPCRs mediates cell-signalling mechanisms leading to hypertrophy, this could be an important mechanism by which the GPCR is able to generate sustained signals for cardiac hypertrophy. Our results suggest that the clathrin-mediated endocytosis machinery may be an important target for the treatment of cardiac hypertrophy because inhibition of b-AR endocytosis may selectively uncouple cardiac hypertrophy while preserving coupling between b-AR and cardiac contractility.
Supplementary material
Supplementary material is available at Cardiovascular Research online. 
